Literature DB >> 16259111

Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs.

Akihiro Suzuki1, Noriharu Shijubo, Gen Yamada, Shingo Ichimiya, Masaaki Satoh, Shosaku Abe, Noriyuki Sato.   

Abstract

The aim of the present study was to compare the usefulness of the peripheral airway cell markers, naspin A and surfactant protein A (SP-A), for distinguishing primary lung adenocarcinoma from adenocarcinomas of other organs in various clinical conditions. Immunohistochemical expression of napsin A and SP-A was analyzed at primary sites of 120 lung carcinomas and 40 adenocarcinomas of other organs, at lung metastatic sites of 32 adenocarcinomas of other organs, and in metastatic lymph nodes of 21 lung adenocarcinomas and 45 adenocarcinomas of other organs. Napsin A and SP-A expressions were compared between primary and recurrent sites in 8 lung adenocarcinomas. Napsin A and SP-A expressions were noted in 84.3% and 53.0% of primary sites of 83 lung adenocarcinomas, respectively, but neither napsin A nor SP-A was expressed at primary sites of other histological types of lung carcinomas or at primary or metastatic sites of adenocarcinomas of other organs. In lung adenocarcinomas, napsin A and SP-A were expressed in metastatic lymph nodes in 81.0% and 19.0%, respectively, and at recurrent sites in 87.5% and 37.5%, respectively. Napsin A is superior to SP-A for distinguishing primary lung adenocarcinoma from adenocarcinomas of other organs at primary, metastatic, and recurrent sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259111     DOI: 10.1016/j.prp.2005.05.010

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  11 in total

1.  ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.

Authors:  Wei Zhao; Hui Wang; Yan Peng; Bo Tian; Lei Peng; Da-Chuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Gastric metastasis from primary lung adenocarcinoma mimicking primary gastric cancer.

Authors:  Min Ji Kim; Ji Hyung Hong; Eun Su Park; Jae Ho Byun
Journal:  World J Gastrointest Oncol       Date:  2015-03-15

3.  Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.

Authors:  Peng Zhang; Yi-Ping Han; Ling Huang; Qiang Li; DA-Lie Ma
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

4.  Ovarian metastasis from non-small cell lung cancer with ALK and EGFR mutations: A report of two cases.

Authors:  Rosemary T Mushi; Yumei Yang; Qian Cai; Ruiguang Zhang; Gang Wu; Xiaorong Dong
Journal:  Oncol Lett       Date:  2016-10-19       Impact factor: 2.967

5.  How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer.

Authors:  Pirmin Schlicke; Christina Kuttler; Christian Schumann
Journal:  Theor Biol Med Model       Date:  2021-06-02       Impact factor: 2.432

6.  Lung cancer diagnosis on ovary mass: a case report.

Authors:  Nunzia Simona Losito; Cono Scaffa; Monica Cantile; Gerardo Botti; Raffaele Costanzo; Angela Manna; Renato Franco; Stefano Greggi
Journal:  J Ovarian Res       Date:  2013-05-10       Impact factor: 4.234

7.  Neuropathology of brain metastases.

Authors:  Melike Pekmezci; Arie Perry
Journal:  Surg Neurol Int       Date:  2013-05-02

8.  Breast metastasis from EGFR-mutated lung adenocarcinoma: A case report and review of the literature.

Authors:  Takayo Ota; Yoshikazu Hasegawa; Akira Okimura; Katsuya Sakashita; Takeshi Sunami; Kiyotaka Yukimoto; Ryugo Sawada; Kazutsugu Sakamoto; Masahiro Fukuoka
Journal:  Clin Case Rep       Date:  2018-06-19

9.  Breast metastasis from EGFR/ALK negative lung adenocarcinoma: A case report.

Authors:  Liyu Cao; Liting Lv
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

10.  Napsin A Expression in Human Tumors and Normal Tissues.

Authors:  Sören Weidemann; Jan Lukas Böhle; Hendrina Contreras; Andreas M Luebke; Martina Kluth; Franziska Büscheck; Claudia Hube-Magg; Doris Höflmayer; Katharina Möller; Christoph Fraune; Christian Bernreuther; Michael Rink; Ronald Simon; Anne Menz; Andrea Hinsch; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Eike Burandt; Rainer Krech; David Dum; Till Krech; Andreas Marx; Sarah Minner
Journal:  Pathol Oncol Res       Date:  2021-04-20       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.